Abstract

Objective: This study monitored circulating plasma levels of soluble vascular cellular adhesion molecule-1 (sVCAM-1), intracellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin)in women with healthy pregnancies, with pregnancy-induced hypertension (PIH), with pre-eclampsia and with pregnancies with isolated intrauterine growth restriction (IUGR) in order to determine whether elevatedconcentrations have a predictive value for the clinical signs of those pregnancy-induced disorders.Methods: Plasma concentrations of sVCAM-1, sICAM-1 and sE-selectin were determined in healthypregnant women at each trimester of pregnancy and in pregnant women with PIH, pre-eclampsia and IUGR using commercial kits.Results: In the group of healthy pregnant women, plasma levels of sVCAM-1,sICAM-1 and sE-selectin did not change throughout pregnancy. No significant differences in the levels of these molecules were observed between healthy pregnant women at the third trimester of pregnancyand women with PIH. In addition, concentrations of soluble adhesion molecules were significantly higher in women with pre-eclampsia than in the group of women with healthy pregnancies. Only sVCAM-1 andsE-selectin levels were significantly higher in women with IUGR compared to healthy pregnant women.Conclusions: Abnormally circulating levels of sVCAM-1, sICAM-1 and sE-selectin may have a predictivevalue for pre-eclampsia and IUGR, as they may be linked with endothelial activation and/or damage.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.